Zarsio (filgrastim) solution for injections and infusions 30 ml/0.5 ml. 1 syringe №5


Manufacturer: Austria



The drug is indicated for the purpose of mobilization of peripheral blood stem cells (CPVC). Long-term use is indicated for children and adults with severe congenital, cyclic or idiopathic neutropenia and neutropenia with an absolute neutrophil count <0.5 × 109 / L in order to increase the number of neutrophils and reduce the frequency of infections. Treatment of sustained neutropenia (absolute neutrophil count ≤1.0 × 109 / L) in patients with advanced HIV infection to reduce the risk of bacterial infections when other methods of treating neutropenia are inappropriate.